Investors must take note of Inovio Pharmaceuticals Inc.’s (INO) performance last week, which was 17.81%.

A new trading day began on June 21, 2022, with Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock priced at $1.615, up 7.50% from the previous day of trading. During the day, the shares moved up to $1.795 and dropped to $1.60 before settling in for the closing price of $1.60. INO’s price has ranged from $1.38 to $9.96 over the past 52 weeks.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -45.00%. Meanwhile, its annual earnings per share averaged -35.60%. With a float of $213.69 million, this company’s outstanding shares have now reached $218.94 million.

The extent of productivity of a business whose workforce counts for 317 workers is very important to gauge. In terms of profitability, gross margin is -166.56, operating margin of -17535.79, and the pretax margin is -17085.39.

Inovio Pharmaceuticals Inc. (INO) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Inovio Pharmaceuticals Inc. is 1.30%, while institutional ownership is 41.20%. The most recent insider transaction that took place on May 16, was worth 17,550. In this transaction Director of this company sold 9,000 shares at a rate of $1.95, taking the stock ownership to the 892,625 shares. Before that another transaction happened on May 16, when Company’s Director sold 3,600 for $1.98, making the entire transaction worth $7,128. This insider now owns 39,416 shares in total.

Inovio Pharmaceuticals Inc. (INO) Latest Financial update

In its latest quarterly report, released on 3/30/2022, the company reported earnings of -$0.36 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -17109.87 while generating a return on equity of -70.55. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -35.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to -7.60% drop over the previous five years of trading.

Inovio Pharmaceuticals Inc. (NASDAQ: INO) Trading Performance Indicators

Here are Inovio Pharmaceuticals Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 227.77.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -0.98 in one year’s time.

Technical Analysis of Inovio Pharmaceuticals Inc. (INO)

The latest stats from [Inovio Pharmaceuticals Inc., INO] show that its last 5-days average volume of 8.97 million was superior to 5.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 53.61%. Additionally, its Average True Range was 0.17.

During the past 100 days, Inovio Pharmaceuticals Inc.’s (INO) raw stochastic average was set at 11.72%, which indicates a significant decrease from 64.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.90% in the past 14 days, which was lower than the 96.43% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.2776, while its 200-day Moving Average is $4.7090. Now, the first resistance to watch is $1.8100. This is followed by the second major resistance level at $1.9000. The third major resistance level sits at $2.0050. If the price goes on to break the first support level at $1.6150, it is likely to go to the next support level at $1.5100. The third support level lies at $1.4200 if the price breaches the second support level.

Inovio Pharmaceuticals Inc. (NASDAQ: INO) Key Stats

With a market capitalization of 364.43 million, the company has a total of 229,041K Shares Outstanding. Currently, annual sales are 1,770 K while annual income is -303,660 K. The company’s previous quarter sales were 200 K while its latest quarter income was -76,910 K.


Citigroup Upgraded Nokia Oyj (NOK) To Buy with Price Target of $6.8

Nokia Oyj (NYSE: NOK), a communications equipment developer, is...

The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...



Don't miss

Chevron Corporation (CVX) provides details about its hydrogen future

The huge hydrogen investment plan of the oil and...

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

Dominion Energy Inc. (D)’s latest performance is not what we had anticipated

On June 29, 2022, Dominion Energy Inc. (NYSE: D) opened at $78.78, higher 0.62% from the last session. During the day, the shares moved...

-25.70% percent quarterly performance for Stellantis N.V. (STLA) is not indicative of the underlying story

A new trading day began on June 29, 2022, with Stellantis N.V. (NYSE: STLA) stock priced at $12.85, down -1.17% from the previous day...

Citizens Financial Group Inc. (CFG) is -7.60% away from 50-day simple Moving Average despite all headwinds

Citizens Financial Group Inc. (NYSE: CFG) kicked off on June 29, 2022, at the price of $36.83, down -1.66% from the previous trading day....


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam